The protein expression levels of RBM10 were consistent with RT-qPCR analysis of 14 pairs of patient cancer and para-cancerous tissues, showing that RBM10 mRNA levels in PAAD tissues were lower than in para-cancerous tissues (P < 0.01) (Figure 1H). This evidence concerns the gene RBM10 and pancreatic adenocarcinoma.